510(k) Report

510(k) · Cleared

Cleared

Thyretain TM Tsi Reporter Bioassay

K092229510(k) TraditionalCleared May 18, 2010299-day reviewClass II21 CFR 866.5870

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostic Hybrids, Inc. · JZO System, Test, Thyroid Autoantibody

Cleared on May 18, 2010 as substantially equivalent to K083391 (Diagnostic Hybrids, Inc., 2009) after a 299-day review. Its family tree reaches back 2 generations to 2003. 1 later device descends from it.

Decided
May 18, 2010
Review
299 days
Class
Class II
Product code
JZO
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K032134 (2003). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2016: 1 descendant clearedK032134 · TSH Receptor Antibody (Trab) Coated Tube (CT) Assay Kit · Kronus Market Development Associates, Inc. · 2003K083391 · Thyroid Stimulating Immunoglobulin Reporter Assay · Diagnostic Hybrids, Inc. · 2009200020052010201520202025
  1. Root · 2 generations backK032134 TSH Receptor Antibody (Trab) Coated Tube (CT) Assay KitKronus Market Development Associates, Inc. · 2003
  2. 1 generation backK083391 Thyroid Stimulating Immunoglobulin Reporter AssayDiagnostic Hybrids, Inc. · 2009
  3. This deviceK092229 Thyretain TM Tsi Reporter BioassayDiagnostic Hybrids, Inc. · 2010
  4. Descendant · cites it directly · 0 of its ownK152061 IMMULITE 2000 TSI Assay, IMMULITE 2000 TSI Calibration Verification…Siemens Healthcare Diagnostics, Inc. · 2016 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K152061IMMULITE 2000 TSI Assay, IMMULITE 2000 TSI Calibration Verification MaterialSiemens Healthcare Diagnostics, Inc. · 2016 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K032134TSH Receptor Antibody (Trab) Coated Tube (CT) Assay KitKronus Market Development Associates, Inc.2003—
−1K083391Thyroid Stimulating Immunoglobulin Reporter AssayDiagnostic Hybrids, Inc.2009—
0 (this device)K092229Thyretain TM Tsi Reporter BioassayDiagnostic Hybrids, Inc.2010—
+1K152061IMMULITE 2000 TSI Assay, IMMULITE 2000 TSI Calibration Verification MaterialSiemens Healthcare Diagnostics, Inc.20161

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
FIG. 1 — Lineage of K092229, 2003–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JZO device

  1. #1 K250250 ADVIA Centaur Anti-Thyroid Peroxidase IIscore 10.5 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K083391Thyroid Stimulating Immunoglobulin Reporter Assay
Summary page 1
…JZO Regulation: 21 CFR § 866.5870, Thyroid Autoantibody Inmmunological Test LEGALLY MARKETED DEVICE Thyretain Tm TSI Reporter BioAssay (TSI Reporter), K083391 DESCRIPTION of DEVICE MODIFICATION The number of wells tested per Positive, Reference and Negative control has been…
Diagnostic Hybrids, Inc.2009—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K152061IMMULITE 2000 TSI Assay, IMMULITE 2000 TSI Calibration Verification MaterialSiemens Healthcare Diagnostics, Inc.20160

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 5.7 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K152061 (Siemens Healthcare Diagnostics, Inc., 2016) has gone furthest, with 0 descendants of its own.

How does its category compare?

All JZO devices

JZO System, Test, Thyroid Autoantibody: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · JZO

1in 2025

2008: 22009: 22010: 12016: 22020: 12023: 22024: 12025: 1
2007high 2 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JZO

Too few JZO 510(k)s in any year since 2007 to give a median.

Recalls per year · JZO

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JZO

44in 2025

2010: 12011: 52012: 42013: 42014: 22015: 42016: 82017: 122018: 352019: 392020: 172021: 192022: 252023: 332024: 292025: 44
2007high 44 (2025) · low 0 (2007)2025

MAUDE reports naming product code JZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—00
20092—00
20101—01
20110—05
20120—04
20130—04
20140—02
20150—04
20162—08
20170—012
20180—035
20190—039
20201—017
20210—019
20220—025
20232—033
20241—029
20251—144
20260—0—

What is it indicated for?

The Thyretain Tm TSI Reporter BioAssay is intended for the qualitative detection in serum of thyroid stimulating autoantibodies to the thyroid stimulating hormone (TSH) receptors (TSHIRs) on the thyroid. The detection of these stimulating autoantibodies, in conjunction with other clinical and laboratory findings, may be useful as an aid in the differential diagnosis of patients with Graves' disease (GD).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092229: Thyretain TM Tsi Reporter Bioassay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K092229

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026